The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
Losing Your Home Close to Retirement Age: What to Consider Before You Sell or Rebuild
Losing your home in a disaster when you’re at or near retirement age can derail your finances and jeopardize the…
Trump administration reassigning acting ICE director
Caleb Vitello, who the administration had chosen to run ICE on an interim basis, is out amid anger from the…
Consumers Are Financing Their Groceries. What Does It Say About the Economy?
Increased use of “buy now, pay later” loans may signal shifting consumer habits, but could also be a troubling sign…